For Alzheimer's Agitation, Promising News from Rexulti (Brexpiprazole)

Rexulti (brexpiprazole) shares positive trial results for treating agitation in Alzheimer's. Following this a bumpy road for another Alzheimer's drug candidate that could supplant the need for antipsychotics to treat behavioral Alzheimer's symptoms, this could be the first such drug approved — if its safety and efficacy data stay on track.

Lundbeck and Otsuka reports positive data from phase 3 trial of

Investigation Questions Drug's Approval for Agitation in AD

Lundbeck, Otsuka drug cut agitation in Alzheimer's patients

First Treatment for Agitation Associated With Alzheimer Disease

REXULTI® (brexpiprazole), MDD

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

Lundbeck carries on Rexulti study after new analysis — MedWatch

Brexpiprazole - Wikipedia

Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for

REXULTI® (brexpiprazole) Agitation associated with dementia due

FAQ for agitation that may happen with dementia due to Alzheimer's

Rexulti: Side effects, dosage, alternatives, and more

Brexpiprazole (Rexulti): Uses, Side Effects, Warnings & More - GoodRx